These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11780196)

  • 21. Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
    Raman JD; Mongan NP; Liu L; Tickoo SK; Nanus DM; Scherr DS; Gudas LJ
    Carcinogenesis; 2006 Mar; 27(3):499-507. PubMed ID: 16344273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of Skp2 and p27kip1 expression in human renal cell carcinoma using tissue chip technique].
    Yao C; Zheng SB; Wu P; Zhang HJ; Jiang YD; Chen T; Qi H; Zhao GZ; Zhao JF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):642-5. PubMed ID: 18495610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic significance of fascin expression in clear cell renal cell carcinoma: systematic analysis of primary and metastatic tumor tissues using a tissue microarray technique.
    Zigeuner R; Droschl N; Tauber V; Rehak P; Langner C
    Urology; 2006 Sep; 68(3):518-22. PubMed ID: 16979727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
    de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D
    Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.
    Matsuyama M; Yoshimura R; Mitsuhashi M; Tsuchida K; Takemoto Y; Kawahito Y; Sano H; Nakatani T
    Oncol Rep; 2005 Jul; 14(1):73-9. PubMed ID: 15944770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
    Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
    Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
    Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
    Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling.
    Kojima T; Shimazui T; Hinotsu S; Joraku A; Oikawa T; Kawai K; Horie R; Suzuki H; Nagashima R; Yoshikawa K; Michiue T; Asashima M; Akaza H; Uchida K
    Oncogene; 2009 Jan; 28(2):297-305. PubMed ID: 18931698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups.
    Seidler HB; Utsuyama M; Nagaoka S; Takemura T; Kitagawa M; Hirokawa K
    Exp Mol Pathol; 2004 Jun; 76(3):224-33. PubMed ID: 15126105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of GRP78 in renal cell carcinoma and its significance.
    Fu W; Wu X; Li J; Mo Z; Yang Z; Huang W; Ding Q
    Urology; 2010 Mar; 75(3):603-7. PubMed ID: 19616278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
    Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
    Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of bcl-2 enhances the efficacy of chemotherapy in renal cell carcinoma.
    Kausch I; Jiang H; Thode B; Doehn C; Krüger S; Jocham D
    Eur Urol; 2005 May; 47(5):703-9. PubMed ID: 15826766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Down-regulated expression of RhoA in human conventional renal cell carcinoma.
    Pu YS; Wang CW; Liu GY; Kuo YZ; Huang CY; Kang WY; Shun CT; Lin CC; Wu WJ; Hour TC
    Anticancer Res; 2008; 28(4B):2039-43. PubMed ID: 18751372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
    Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
    J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
    Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
    Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of plakoglobin in renal cell carcinoma.
    Buchner A; Oberneder R; Riesenberg R; Keiditsch E; Hofstetter A
    Anticancer Res; 1998; 18(6A):4231-5. PubMed ID: 9891472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.